PROSTATIC DYSPLASIA

PROSTATIC DYSPLASIA was reported 45 times

These drug classes are most commonly taken by patients reporting PROSTATIC DYSPLASIA:

# Drug Count
0 HMG-CoA Reductase Inhibitor [EPC] 7
1 Proton Pump Inhibitor [EPC] 7
2 Nonsteroidal Anti-inflammatory Drug [EPC] 6
3 5-alpha Reductase Inhibitor [EPC] 4
4 Angiotensin 2 Receptor Blocker [EPC] 4
5 Platelet Aggregation Inhibitor [EPC] 4
6 Tumor Necrosis Factor Blocker [EPC] 4
7 Calcium Channel Blocker [EPC] 3
8 Dihydropyridine Calcium Channel Blocker [EPC] 3
9 Microtubule Inhibitor [EPC] 3
10 beta-Adrenergic Blocker [EPC] 3
11 Angiotensin Converting Enzyme Inhibitor [EPC] 2
12 Corticosteroid [EPC] 2
13 Loop Diuretic [EPC] 2
14 Aldosterone Antagonist [EPC] 1
15 Aminosalicylate [EPC] 1
16 Atypical Antipsychotic [EPC] 1
17 Benzodiazepine [EPC] 1
18 Expectorant [EPC] 1
19 GLP-1 Receptor Agonist [EPC] 1
20 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1
21 Hepatitis C Virus NS5A Inhibitor [EPC] 1
22 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
23 Histamine-2 Receptor Antagonist [EPC] 1
24 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
25 Insulin Analog [EPC] 1
26 Insulin [EPC] 1
27 Integrin Receptor Antagonist [EPC] 1
28 Interferon beta [EPC] 1
29 Interleukin-17A Antagonist [EPC] 1
30 Nitrate Vasodilator [EPC] 1
31 Nitroimidazole Antimicrobial [EPC] 1
32 Osmotic Laxative [EPC] 1
33 Phosphodiesterase 5 Inhibitor [EPC] 1
34 Proteasome Inhibitor [EPC] 1
35 Recombinant Human Growth Hormone [EPC] 1
36 Serotonin Reuptake Inhibitor [EPC] 1
37 Sulfonylurea [EPC] 1
38 Tetracycline-class Drug [EPC] 1
39 Thalidomide Analog [EPC] 1
40 Xanthine Oxidase Inhibitor [EPC] 1
41 alpha-Adrenergic Blocker [EPC] 1
42 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1